Copyright: ©Author(s) 2026.
World J Hepatol. Apr 27, 2026; 18(4): 114804
Published online Apr 27, 2026. doi: 10.4254/wjh.v18.i4.114804
Published online Apr 27, 2026. doi: 10.4254/wjh.v18.i4.114804
Figure 1 Identification of differentially expressed genes after interferon treatment for chronic hepatitis B through transcriptomic analysis.
A: Principal component analysis (PCA) of all differentially expressed genes (DEGs) across the four groups: Untreated (group A); 1-month interferon (IFN) treatment (group B); 3-month IFN treatment (group C); 6-month IFN treatment (group D); B: PCA comparing (B vs A); C: PCA comparing (B vs C); D: PCA comparing (C vs D); E: Venn diagram showing the overlap of all DEGs across the four groups; F: Volcano plots of DEGs in the comparisons (B vs A); G: Volcano plots of DEGs in the comparisons (C vs B); H: Volcano plots of DEGs in the comparisons (D vs C). PCA: Principal component analysis.
- Citation: Ye XY, He XZ, Hu ZT, Zheng FF, Huang XG, Xie XM, Chen FH, Ou HB, Qiu RX. Integrated transcriptomics and metabolomics reveal neutrophil extracellular trap associated with interferon treatment for chronic hepatitis B. World J Hepatol 2026; 18(4): 114804
- URL: https://www.wjgnet.com/1948-5182/full/v18/i4/114804.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i4.114804